Coating of human decay accelerating factor (hDAF) onto medical devices to improve biocompatibility

Complement Activation during Cardiopulmonary Bypass

Dennis E. Chenoweth, Steven W. Cooper, Tony E. Hugli et al. · New England Journal of Medicine · 1981 · 1.2K citations

Medicine, Immunology, Surgery +12

Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system.

A Nicholson-Weller, Joseph J. Burge, D T Fearon et al. · The Journal of Immunology · 1982 · 588 citations · Full text

Life Sciences, Biochemistry, Immunology +11

Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes.

M. Edward Medof, Taroh Kinoshita, Victor Nussenzweig · The Journal of Experimental Medicine · 1984 · 563 citations · Full text

Life Sciences, Cell Biology, Immunology +15

A New Non-Thrombogenic Surface Prepared by Selective Covalent Binding of Heparin Via a Modified Reducing Terminal Residue

Olle Larm, Rolf Larsson, Per Olsson · Biomaterials Medical Devices and Artificial Organs · 1983 · 439 citations

Medicine, Bioengineering, Materials Science +15

Amelioration of lupus-like autoimmune disease in NZB/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5.

Yijun Wang, Qiongzheng Hu, Joseph A. Madri et al. · Proceedings of the National Academy of Sciences · 1996 · 341 citations · Full text

Medicine, Immunology, Pathology +17